Loading...
Ritonavir — Export Intelligence Report
2025-Q4 · TransData Nexus
PHARMA TRADE INTELLIGENCE
INDIA EXPORT INTELLIGENCE REPORT
Ritonavir
2025-Q4
Comprehensive analysis of India’s ritonavir export trade — suppliers, buyers, prices, routes, and every shipment record.
28
Shipments
$5.75M
Trade Value
8
Suppliers
18
Buyers
18
Countries
Scan for online report
Talk to our analyst: +91 95950 78788
https://transdatanexus.com/pharmaceutical/ritonavir
01
PART I — OVERVIEW
Executive Summary
At-a-glance KPIs, key findings, and strategic positioning of India’s ritonavir trade — 2025-Q4
KEY TAKEAWAY
Ritonavir 2025-Q4 exports total $5.8M across 18 countries, with HETERO LABS LTD commanding 90.8% market share.
TOTAL SHIPMENTS
28
2025-Q4
EXPORT VALUE
$5.8M
FOB USD
TOTAL QUANTITY
16.6M
units shipped
INDIAN SUPPLIERS
8
unique exporters
GLOBAL BUYERS
18
unique importers
DESTINATIONS
18
countries
MEDIAN UNIT PRICE
$0.457
per unit
TOP-5 SHARE
99.9%
of total USD
BRANDED SHARE
35.7%
10 shipments
DOSAGE FORMS
3
product types
6 KEY FINDINGS
1
HETERO LABS LTD is India's #1 Ritonavir exporter with $5.2M (90.8% market share).→ §5, Indian Supplier Rankings
2
Ritonavir reached 18 countries, with Belgium as the top destination ($5.1M).→ §4, Global Destination Map
3
Market concentration is high (HHI: 8280) — top 8 suppliers control 100.0% of exports.→ §5, Indian Supplier Rankings
4
94.4% of buyers (17 of 18) source from a single Indian supplier — potential poaching opportunities.→ §6, Global Buyer Rankings
5
Tablet dominates (91.2%) across 3 dosage forms.→ §7, Price Benchmarks
6
18 countries have ≤5 Indian suppliers — easy-entry markets for SME exporters.→ §9, Strategic Opportunities
WHO THIS REPORT IS FOR
S SUPPLIERS (Indian pharma exporters)
- See which buyers your competitors are shipping to, at what price, through which ports
- Identify buyers that are single-sourced (poaching opportunities)
- Benchmark your pricing and catalog vs the Top 25
B BUYERS (global importers)
- Discover which Indian exporters supply this product and what they sell
- Benchmark the price you are paying vs the market median by country and dosage
- Identify alternative suppliers with proven exports to similar destinations
Figure 1.1 HETERO LABS LTD leads in volume — how do 8 exporters compare on price × volume?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Every bubble is one Indian ritonavir exporter. X-axis = shipment count; Y-axis = average unit price; bubble size = total revenue. Dashed lines split at the median — exporters in the top-right (Bulk Leaders) combine high volume with premium pricing.
HOW TO READ THIS REPORT
60 seconds
Scan this page — KPIs, thesis, flagship chart, top findings
5 minutes
Read every Key Takeaway line across §1–§9
30 minutes
Read sections tagged for your role ([S] or [B]) end-to-end
In depth
Drill into §10 for your country · supplier / buyer directories at end
02
PART I — OVERVIEW
About This Report
Data sources, methodology, trust signals, and what this Ritonavir report covers
KEY TAKEAWAY
Every figure in this report is grounded in real commercial ritonavir trade records. Data comes from official customs filings and public trade sources, runs through a multi-layer quality process, and lands in a clean, consistent report you can rely on.
S FOR SUPPLIERS
Every competitor benchmark, market share figure, and buyer list in this report comes from verified commercial shipments — not surveys or estimates. Use them with confidence when planning your next pitch.
B FOR BUYERS
Every supplier profile, price benchmark, and trade route in this report reflects what that supplier actually ships — real volumes, real destinations, real prices. Use them to qualify and compare Indian ritonavir suppliers.
§2.1 Reporting parameters · the scope of this 2025-Q4 Ritonavir India trade report
Product scope
Ritonavir
All variants merged — branded and generic formulations of ritonavir
Time period
2025-Q4
October, November, December 2025 — a single-quarter snapshot
Data sources
Official & public trade records
Government customs filings, public trade databases and licensed commercial feeds
Geography
India origin → global
Indian sea and air ports shipping to destination markets worldwide
Currency
USD (FOB)
Declared Free-on-Board value at the Indian port of loading
Shipments analysed
28
Every commercial ritonavir trade record in the period, aggregated and deduplicated
§2.2 Our quality process · Figure 2.1
Figure 2.1 From raw trade records to a clean report — the four quality pillars.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Raw trade data (left) flows through four quality checks — source verification, format standardisation, entity matching, and deduplication — to produce the clean, reliable data (right) behind every chart and table in this report.
§2.3 Trust signals · what you can rely on in the numbers you read
DATA COVERAGE
10M+
Pharmaceutical trade records across the full TransData Nexus platform.
COUNTRIES
150+
Origin and destination countries covered in the global pharma trade database.
DATA ACCURACY
99.9%
Validation rate on core fields — supplier, buyer, product, quantity, value.
UPDATE FREQUENCY
Daily
Platform refresh cadence. This report is a snapshot from the same live data.
§2.4 Limitations · what the data does and does not tell you
WHAT THIS DATA DOES AND DOES NOT SAY
- Prices are at the Indian port of loading (FOB), not the final delivered cost in the destination country. Freight, insurance, import duty and local margin are not included.
- This is a single-quarter snapshot. Multi-quarter trends, year-over-year growth and historical comparisons are available on the full platform.
- A small number of records have incomplete transport mode or destination port fields; these appear blank in the shipment register but are still counted in totals.
- This report is a commercial intelligence tool, not a legal audit. For high-stakes decisions, cross-reference with the underlying trade records via the full platform.
03
PART II — MARKET STRUCTURE
Quarterly Trade Overview
Monthly trends, regional performance, and ranking shifts — 2025-Q4
KEY TAKEAWAY
2025-Q4 followed a mixed: Oct $5.7M, Nov $18.7K, Dec $115. Shipment counts were mixed across the quarter.
S FOR SUPPLIERS
Track which months your competitors were most active, which destinations rose or fell, and whether the Nov dip hit your segment. The bump charts show rank movement — watch for rivals climbing past you.
B FOR BUYERS
Identify whether your current Indian supplier maintained steady shipments through the quarter, or whether they pulled back. Steady suppliers during dips signal reliable partnerships.
1
$5.7M
Oct USD
15 shipments
2
$18.7K
Nov USD
-99.7% MoM
3
$115
Dec USD
-99.4% MoM
4
Mixed
Q4 growth shape
Oct → Nov → Dec
Fig 3.1 Nov dipped 99.7% in USD but shipment count kept steady.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = monthly USD. Orange line = shipment count. When bars drop but line rises, average shipment value fell. Insight: Oct opened at $5.7M, making it the strongest month by value.
Fig 3.2 Q4 cumulative USD reached $5.8M.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The curve shows the running total across the quarter. A steeper slope means that month contributed more revenue. Insight: The curve’s steepest section reveals which month drove the most trade value.
Fig 3.3 $5.7M dip in Nov, $19K decline in Dec.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Blue bars = absolute monthly value. Red = month-over-month loss; green = gain. Insight: Nov’s dip was fully recovered by Dec.
Fig 3.4 Regional breakdown by month — which corridors swung most?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each coloured layer is one destination region. Layer height = USD in that month. Insight: The top region contributed the most, while the smallest region had the least volume.
§3.1 Monthly summary
| Oct | $5.7M | 15 shipments |
| Nov | $19K | 10 shipments |
| Dec | $115 | 3 shipments |
| Q4 Total | $5.8M | 28 shipments |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 3.5 Top 10 destination countries by monthly USD rank — who’s rising?
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a country’s monthly rank. Lines crossing = rank swaps. Insight: Belgium held #1 throughout the quarter.
Fig 3.6 Top 8 Indian exporters by monthly USD rank.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each line traces a supplier’s monthly rank. Flat = stable position; crossing = rank change. Insight: MYLAN LABORATORIES LTD maintained its leading position.
04
PART II — MARKET STRUCTURE
Global Destination Map
Which countries import ritonavir from India, how much they buy, and who supplies each market
KEY TAKEAWAY
Belgium absorbs 88.8% of India’s 2025-Q4 ritonavir trade ($5.1M). Beyond the top 10 destinations, 18 countries have fewer than 5 Indian suppliers each — white-space markets where new entrants face minimal competition. Africa has 6 destination countries, the widest regional diversity.
S FOR SUPPLIERS
Use the flow map and lanes table to see which destinations your competitors dominate. For small and mid-size suppliers: look beyond the leading markets — the 18 countries in the long tail have fewer than 5 Indian suppliers each and low competitive barriers.
B FOR BUYERS
Find your country on the map to see how much ritonavir India ships to your market, who the top suppliers are, and whether you’re in a concentrated or competitive corridor.
Asia
$146K
2.5% of trade
6 countries · 7 shipments
Europe
$5.4M
94.5% of trade
3 countries · 8 shipments
Americas
$95K
1.7% of trade
3 countries · 5 shipments
Africa
$73K
1.3% of trade
6 countries · 8 shipments
Fig 4.1 Belgium is the #1 corridor ($5.1M) — 18 flow arcs from India radiate across 4 continents.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: The world map shows every country colored by how much Indian ritonavir it receives (light = low, dark = high). Orange arcs radiate from India to the top 18 destinations; arc thickness = USD value. All destinations are labeled with country name + USD.
§4.1 Top 10 bilateral trade lanes (India → destination) with top Indian suppliers
| # | Destination | Total USD | Ships | #1 Indian supplier | USD | #2 Indian supplier | USD | #3 Indian supplier | USD |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Belgium | $5.1M | 6 | HETERO LABS LTD | $5.1M | MYLAN LABORATORIES LTD | $3K | — | — |
| 2 | Russia | $292K | 1 | JODAS EXPOIM PVT LTD | $292K | — | — | — | — |
| 3 | Thailand | $123K | 1 | MYLAN LABORATORIES LTD | $123K | — | — | — | — |
| 4 | Chile | $86K | 1 | ANNORA PHARMA PVT LTD | $86K | — | — | — | — |
| 5 | South Africa | $46K | 2 | HETERO LABS LTD | $46K | — | — | — | — |
| 6 | Latvia | $40K | 1 | HETERO LABS LTD | $40K | — | — | — | — |
| 7 | Saudi Arabia | $22K | 1 | HETERO LABS LTD | $22K | — | — | — | — |
| 8 | Gabon | $18K | 1 | M D PHARMACY | $18K | — | — | — | — |
| 9 | Grenada | $8K | 3 | HETERO LABS LTD | $8K | — | — | — | — |
| 10 | Togo | $4K | 1 | HETERO LABS LTD | $4K | — | — | — | — |
Table 4.1 — Top 10 destination countries ranked by trade value, with the largest Indian suppliers for each market.
Fig 4.2 Asia leads at 2.5% of USD — but Belgium is the single largest market.
Region → country treemap
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Column width = region USD share. Within each column, cells are stacked by country, height = share within region.
§4.2 Destination concentration
88.8%
#1 country share
Belgium alone
98.3%
Top 5 share
5 of 18 countries
100.0%
Top 15 share
Long tail of 3 countries = 0.0%
HHI 7911
Destination HHI
Highly concentrated
18
Countries served
Global pharma reach from India
6
Africa countries
Widest regional diversity
Source: TransData Nexus trade data platform
05
PART III — WHO’S IN THIS MARKET
Indian Supplier Rankings & Profiles
8 Indian exporters ranked by value — profiles, portfolios, and competitive intelligence
KEY TAKEAWAY
HETERO LABS LTD ($5.2M, 90.8% share) and JODAS EXPOIM PVT LTD ($291.9K) together control 95.9% of India’s 2025-Q4 ritonavir trade. The top 5 suppliers hold 99.9%. 8 companies shipped at least once.
S FOR SUPPLIERS
Find your rank, your competitors’ ranks, and the gap in USD/share between you. The profile pages show each top supplier’s buyer portfolio, dosage mix and route map — your competitive-intelligence toolkit.
B FOR BUYERS
Find potential Indian ritonavir suppliers ranked by size, catalog breadth and destination reach. The profile pages reveal which suppliers have proven trade lanes to your region.
Fig 5.1 HETERO LABS LTD leads by $4.9M over JODAS EXPOIM PVT LTD — top 8 Indian exporters ranked by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian supplier ranked by USD. The (#N) shows their rank by shipment count — mismatches reveal pricing strategy. Insight: MCCOY PHARMA PVT is #6 by value but #3 by volume.
Fig 5.2 HETERO LABS LTD also leads by shipment count (16) but ranking shifts for volume-heavy players
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same suppliers re-ranked by shipment count. The (#N) shows their rank by USD value. Insight: MCCOY PHARMA PVT moves from #3 by volume to #6 by value — fewer but higher-value shipments.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — Archetypes & Concentration
How India’s 8 ritonavir suppliers split into strategic segments
KEY TAKEAWAY
2 suppliers (25%) generate 95.9% of total trade value. The market splits into four archetypes: Market Leaders, High-Value specialists, Volume players, and a long tail.
Fig 5.3 HETERO LABS LTD and JODAS EXPOIM PVT LTD sit in the leaders zone — high volume AND high value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble is one Indian supplier. X-axis = shipment count (log scale); Y-axis = total USD value (log scale); bubble size = revenue. Blue dashed lines split at the median. Market Leaders (top-right) combine high volume with high value. Premium Niche (top-left) ship fewer but higher-value consignments. Volume Players (bottom-right) compete on quantity. Long-Tail (bottom-left) are small or occasional exporters. Conclusion: the log scale reveals clear strategic clusters — use this map to identify where your company sits relative to competitors.
Fig 5.4 25% of suppliers = 95.9% of USD — classic concentration.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Top bar = supplier %, bottom bar = USD %. The gap = market concentration.
Product variety — how many formulations each supplier ships
| # | Supplier | Dosage forms | Countries | USD |
|---|---|---|---|---|
| 1 | MYLAN LABORATORIES LTD | 2 | 5 | $129K |
| 2 | HETERO LABS LTD | 1 | 9 | $5.2M |
| 3 | JODAS EXPOIM PVT LTD | 1 | 1 | $292K |
| 4 | ANNORA PHARMA PVT LTD | 1 | 1 | $86K |
| 5 | M D PHARMACY | 1 | 1 | $18K |
| 6 | SPR ONCOCARE PVT LTD | 1 | 1 | $3 |
| 7 | MCCOY PHARMA PVT LTD | 0 | 1 | $3K |
| 8 | VATS INDUSTRIES PVT LTD | 0 | 1 | $739 |
Table 5.1 — The more dosage forms a supplier ships, the more versatile their manufacturing capability.
05
PART III — WHO’S IN THIS MARKET
Supply Landscape — India Origin Geography & Concentration
Which Indian cities and states are the ritonavir manufacturing hubs
KEY TAKEAWAY
Hyderabad and Hyderbad together account for $5.5M of India’s 2025-Q4 ritonavir trade.
Fig 5.5 Hyderabad (1 exporters, $5.2M) and Hyderbad (1 exporters, $292K) are India’s ritonavir capitals.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Orange bubbles mark major pharma hub cities; bubble size = USD value. Every hub labeled.
§5.1 Supplier concentration metrics
99.9%
Top 5 share
5 of 8 suppliers
100.0%
Top 8 share
8 of 8 suppliers
95.9%
Top 25% share
2 suppliers = 96% USD
HHI 8280
Supplier HHI
Concentrated
8
Total suppliers
shipped Ritonavir in 2025-Q4
10+ cities
Indian hubs
Hyderabad and Hyderbad lead
§5.2 Coming next: 2 exporter deep-dive profiles
Each of the top 2 suppliers gets a dedicated 2-page profile with:
- 6 KPI cards — trade value, shipments, countries, buyers, avg ship value, branded share
- Dosage form breakdown — what formulations they ship
- Monthly trend — Oct / Nov / Dec trajectory
- Trade flow map — supplier → country → importer connections
- Buyer portfolio with lock-in analysis
SUPPLIER PROFILES IN THIS REPORT
| #1 | HETERO LABS LTD | $5.2M |
| #2 | MYLAN LABORATORIES LTD | $129K |
#1
2025-Q4 USD
$5.2M
90.8% market share
SHIPMENTS
16
avg $326K/ship
COUNTRIES
9
destination markets
BUYERS
8
6 single-sourced
BRANDED
31%
of shipments
DOSAGE FORMS
1
product types
TOP 9 DESTINATIONS
Belgium is the #1 market at $5.1M (98% of trade), followed by South Africa at $46K. 9 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Belgium | $5.1M | 5 | 97.7% |
| 2 | South Africa | $46K | 2 | 0.9% |
| 3 | Latvia | $40K | 1 | 0.8% |
| 4 | Saudi Arabia | $22K | 1 | 0.4% |
| 5 | Grenada | $8K | 3 | 0.1% |
| 6 | Togo | $4K | 1 | 0.1% |
| 7 | Saint Lucia | $2K | 1 | 0.0% |
| 8 | Iran | $644 | 1 | 0.0% |
| 9 | Azerbaijan | $3 | 1 | 0.0% |
MONTHLY TREND
Oct peaked at $5.2M. Dec was the weakest at $3.
PRODUCT MIX
Tablet dominates at 100% of trade.
TOP BUYERS · 6/6 LOCKED IN
6 of 6 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| EXPEDITORS INTERNATION… | Belgium | $5.1M | ⚠ Locked |
| Undisclosed buyer | South Africa | $53K | N/A |
| SIAMAGNIPHARMA | Latvia | $40K | ⚠ Locked |
| SAUDI AMAROX FOR INDUS… | Saudi Arabia | $22K | ⚠ Locked |
| MINISTERE DE LA SA | Togo | $4K | ⚠ Locked |
| Undisclosed buyer | Grenada | $2K | N/A |
| RESIDENT REPRESENTATIV… | Iran | $644 | ⚠ Locked |
| MINISTRY OF HEALTH OF … | Azerbaijan | $3 | ⚠ Locked |
#1
EXPORTER PROFILE #1 OF 2 — TRADE FLOW MAP
HETERO LABS LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P1.3 Belgium absorbs $5.1M — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 2 importers per destination.
#3
EXPORTER PROFILE #2 OF 2
MYLAN LABORATORIES LTD
Nashik · India’s #3 ritonavir supplier by USD · 2025-Q4
2025-Q4 USD
$129K
2.2% market share
SHIPMENTS
5
avg $26K/ship
COUNTRIES
5
destination markets
BUYERS
5
5 single-sourced
BRANDED
40%
of shipments
DOSAGE FORMS
2
product types
TOP 5 DESTINATIONS
Thailand is the #1 market at $123K (95% of trade), followed by Belgium at $3K. 5 countries served.
| # | Country | USD | Ships | Share |
|---|---|---|---|---|
| 1 | Thailand | $123K | 1 | 95.4% |
| 2 | Belgium | $3K | 1 | 2.7% |
| 3 | Kenya | $2K | 1 | 1.3% |
| 4 | Mauritania | $713 | 1 | 0.6% |
| 5 | Azerbaijan | $108 | 1 | 0.1% |
MONTHLY TREND
Oct peaked at $123K. Dec was the weakest at $108.
PRODUCT MIX
Powder dominates at 95% of trade. Tablet (4.6%) and others are secondary formulations.
TOP BUYERS · 5/5 LOCKED IN
5 of 5 buyers source exclusively from this supplier — high lock-in with low competitive threat.
| Buyer | Country | USD | Status |
|---|---|---|---|
| ATLANTA MEDICARE CO LTD | Thailand | $123K | ⚠ Locked |
| MSF SUPPLY ASBL | Belgium | $3K | ⚠ Locked |
| SURGILINKS LTD | Kenya | $2K | ⚠ Locked |
| SECRETARIAT EXECUTIF N… | Mauritania | $713 | ⚠ Locked |
| ZEYTUN PHARMACEUTICALS… | Azerbaijan | $108 | ⚠ Locked |
#3
EXPORTER PROFILE #2 OF 2 — TRADE FLOW MAP
MYLAN LABORATORIES LTD — Supplier → Country → Importer
5 destination countries, top 5 importers per country
Fig 5.P2.3 Thailand absorbs $123K — the thickest ribbon.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian supplier. Middle = destination countries (ordered by USD). Right = importers within each country. Ribbon thickness = USD value; color = country. Every node labeled with name + USD + ships. Showing top 5 destinations and up to 1 importers per destination.
06
PART III — WHO’S IN THIS MARKET
Global Buyer Rankings & Intelligence
18 importers across 18 countries — who is buying Indian ritonavir and how much
KEY TAKEAWAY
The demand side is dramatically more fragmented than supply: the top 16 importers together hold only 99.0% of total USD. 94% of buyers source from a single Indian supplier — a vast pool of lock-in candidates.
S FOR SUPPLIERS
Find the importers buying from your competitors. The rankings reveal who has volume, who pays well, and who sources from multiple Indian suppliers (potential pitch targets).
B FOR BUYERS
See where you rank among global importers of Indian ritonavir. Compare your USD and shipment count against peers in your country and dosage segment.
Fig 6.1 EXPEDITORS INTERNATIONAL NV is the #1 importer at $5.1M (88.7%) — top 16 by trade value
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one global importer ranked by USD.
Fig 6.2 Re-ranked by shipment count — compare with Fig 6.1 for divergences
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Same 16 importers re-ranked by shipment count.
§6.1 Sourcing diversity — how many Indian suppliers does each buyer use?
94%
Single-source
17 buyers rely on exactly 1 Indian supplier
0%
Dual-source
0 buyers use 2 Indian suppliers
6%
Multi-source (3–4)
1 buyers diversified across 3–4
0%
Broad-source (5+)
0 buyers with 5+ Indian suppliers
06
PART III — WHO’S IN THIS MARKET
Single-Source Buyers & Price Benchmark
Lock-in opportunities grouped by country + where each buyer sits on the price spectrum
KEY TAKEAWAY
These importers source ritonavir from exactly one Indian supplier. For each one, the table shows the incumbent, price, and dosage.
S FOR SUPPLIERS
This is your target list. Each row is a buyer locked into one competitor. Offer 5–10% better pricing to win the second-source slot.
B FOR BUYERS
If you see your company here, you are fully dependent on one Indian supplier. Consider qualifying a second source.
§6.2 Single-source lock-in by country
Belgium 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| EXPEDITORS INTERNATION… | HETERO LABS LTD | $5.1M | $0.566 | Tablet |
| MSF SUPPLY ASBL | MYLAN LABORATORIES LTD | $3K | $0.238 | Tablet |
Azerbaijan 2 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ZEYTUN PHARMACEUTICALS… | MYLAN LABORATORIES LTD | $108.486 | $0.0030 | Tablet |
| MINISTRY OF HEALTH OF … | HETERO LABS LTD | $3.321 | $0.0023 | Tablet |
Russia 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| OOO JODAS EXPOIM | JODAS EXPOIM PVT LTD | $292K | $0.090 | Capsule |
Thailand 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| ATLANTA MEDICARE CO LTD | MYLAN LABORATORIES LTD | $123K | $123.781 | Powder |
Chile 1 single-source buyers
| Importer | Current supplier | USD | Unit $ | Dosage |
|---|---|---|---|---|
| SEVEN PHARMA CHILE SPA | ANNORA PHARMA PVT LTD | $86K | $0.027 | Capsule |
§6.3 Price positioning — top 16 importers
| # | Importer | Country | USD | $/ship | Tier |
|---|---|---|---|---|---|
| 1 | EXPEDITORS INTERNATI… | Belgium | $5.1M | $1.0M | Premium |
| 2 | OOO JODAS EXPOIM | Russia | $292K | $292K | Premium |
| 3 | ATLANTA MEDICARE CO … | Thailand | $123K | $123K | Premium |
| 4 | SEVEN PHARMA CHILE SPA | Chile | $86K | $86K | Premium |
| 5 | SIAMAGNIPHARMA | Latvia | $40K | $40K | Premium |
| 6 | SAUDI AMAROX FOR IND… | Saudi Arabia | $22K | $22K | Mid |
| 7 | OFFICE PHARMACEUTIQU… | Gabon | $18K | $18K | Mid |
| 8 | MINISTERE DE LA SA | Togo | $4K | $4K | Budget |
| 9 | MSF SUPPLY ASBL | Belgium | $3K | $3K | Budget |
| 10 | SURGILINKS LTD | Kenya | $2K | $2K | Budget |
| 11 | ALL NATIONS PHARMACE… | Sierra Leone | $1K | $1K | Budget |
| 12 | SECRETARIAT EXECUTIF… | Mauritania | $712.782 | $713.000 | Budget |
| 13 | RESIDENT REPRESENTAT… | Iran | $644.064 | $644.000 | Budget |
| 14 | ZEYTUN PHARMACEUTICA… | Azerbaijan | $108.486 | $108.000 | Budget |
| 15 | MINISTRY OF HEALTH O… | Azerbaijan | $3.321 | $3.000 | Budget |
| 16 | SHIP FLIX | United Arab Emirates | $2.720 | $3.000 | Budget |
06
PART III — WHO’S IN THIS MARKET
Market Relationship Map
The top 8 × 16 supplier ↔ buyer network as a circular flow diagram
Fig 6.3 HETERO LABS LTD → EXPEDITORS INTERNATIONAL NV is the strongest relationship.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left semicircle = top 8 Indian suppliers; right = top 16 global buyers. Arc length = total USD; colored ribbons = individual relationships, thickness = USD value. Insight: follow the thickest ribbons to identify the dominant trading pairs.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
How Indian ritonavir prices vary by supplier, country and dosage form
KEY TAKEAWAY
Ritonavir prices span 54797× ($0.0023 → $123.78). The coefficient of variation is 2.54. Dosage form, not destination, is the primary price driver.
S FOR SUPPLIERS
Use the box plot to see where your product sits on the price spectrum. The tornado chart shows exactly where you sit relative to the market median.
B FOR BUYERS
Use this section to benchmark the price you pay against the market. The percentile strip tells you if your current supplier is charging you premium, mid-market or budget rates.
§7.1 Price distribution · Table 7.1
| Statistic | Value | Interpretation |
|---|---|---|
| Min | $0.0023 | Lowest observed unit price |
| P5 | $0.012 | 5th percentile |
| P25 | $0.181 | 25th percentile (Q1) |
| Median | $0.457 | 50th percentile (Q2) |
| P75 | $3.57 | 75th percentile (Q3) |
| P95 | $34.16 | 95th percentile |
| Max | $123.78 | Highest observed unit price |
| Mean | $9.54 | Arithmetic average |
| CV | 254% | Coefficient of variation (std/mean) |
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
Fig 7.1 VATS INDUSTRIES PVT LTD prices at $36.97/unit vs market median $0.457.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar shows one supplier’s average unit price relative to the market median (dashed line). Red = above median (premium), green = below (budget).
COMMODITY KINGS
high volume · low unit price
Bulk API/tablet. Largest absolute USD despite lowest per-unit prices. e.g. JODAS EXPOIM PVT Sourcing: best for cost-driven procurement.
BULK LEADERS
high volume · premium price
Branded-generic leaders, above-median pricing. e.g. HETERO LABS LTD Sourcing: hardest to displace; compete on relationship.
LONG-TAIL
low volume · low unit price
Spot/opportunistic players. Sourcing: first to approach for new tenders.
PREMIUM NICHE
low volume · premium price
Sterile injectables and infusions. Hospital-grade. Sourcing: expect 10× price vs tablet.
07
PART IV — MARKET BEHAVIOR
Price Benchmarks & Analysis
Outlier forensics and the procurement cheat sheet — what to expect to pay by country × dosage
KEY TAKEAWAY
Extreme prices are real: the highest are specialty/sterile formulations; the lowest are bulk API. The cheat sheet matrix is the take-home reference for procurement teams.
§7.2 Outlier forensics — top 10 highest and 10 lowest unit prices
↑ TOP 10 HIGHEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Oct 2025 | MYLAN LABORATORI… | Thailand | Powder | 997 | $123K | $123.78 | Specialty / small-batch |
| Nov 2025 | VATS INDUSTRIES … | Iraq | — | 20 | $739.48 | $36.97 | Specialty / small-batch |
| Nov 2025 | HETERO LABS LTD | Grenada | Tablet | 96 | $3K | $28.93 | Specialty / small-batch |
| Nov 2025 | HETERO LABS LTD | Grenada | Tablet | 96 | $2K | $25.99 | Specialty / small-batch |
| Nov 2025 | HETERO LABS LTD | Grenada | Tablet | 96 | $2K | $25.99 | Specialty / small-batch |
| Nov 2025 | HETERO LABS LTD | Saint Lucia | Tablet | 216 | $2K | $8.59 | Specialty / small-batch |
| Oct 2025 | M D PHARMACY | Gabon | Tablet | 2K | $18K | $7.55 | Specialty / small-batch |
| Nov 2025 | MCCOY PHARMA PVT… | Sierra Leone | — | 560 | $1K | $2.24 | Specialty / small-batch |
| Nov 2025 | MCCOY PHARMA PVT… | Sierra Leone | — | 560 | $1K | $2.24 | Specialty / small-batch |
| Oct 2025 | HETERO LABS LTD | Belgium | Tablet | 1.2M | $673K | $0.585 | Bulk volume discount |
↓ TOP 10 LOWEST USD/UNIT
| Date | Exporter | Country | Dosage | Qty | USD | $/unit | Why |
|---|---|---|---|---|---|---|---|
| Dec 2025 | HETERO LABS LTD | Azerbaijan | Tablet | 1K | $3.32 | $0.0023 | Bulk generic tablet |
| Dec 2025 | MYLAN LABORATORI… | Azerbaijan | Tablet | 36K | $108.49 | $0.0030 | Bulk generic tablet |
| Oct 2025 | ANNORA PHARMA PV… | Chile | Capsule | 3.1M | $86K | $0.027 | Bulk volume discount |
| Oct 2025 | HETERO LABS LTD | South Africa | Tablet | 280K | $14K | $0.050 | |
| Oct 2025 | HETERO LABS LTD | South Africa | Tablet | 563K | $32K | $0.056 | |
| Oct 2025 | JODAS EXPOIM PVT… | Russia | Capsule | 3.3M | $292K | $0.090 | Bulk volume discount |
| Dec 2025 | SPR ONCOCARE PVT… | United Arab Emirates | Tablet | 20 | $2.72 | $0.136 | Small sample / trial shipment |
| Oct 2025 | HETERO LABS LTD | Togo | Tablet | 23K | $4K | $0.197 | |
| Oct 2025 | HETERO LABS LTD | Iran | Tablet | 3K | $644.06 | $0.199 | |
| Nov 2025 | MYLAN LABORATORI… | Mauritania | Tablet | 3K | $712.78 | $0.233 |
§7.3 Procurement cheat sheet — median USD/unit by country × dosage
Fig 7.2 Median unit price by country × dosage form — darker cells = higher prices.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each cell shows the median price per unit for that country-dosage combination. Dark blue = expensive, light = cheap. Blank cells = no shipments in that combination.
NEGOTIATION RANGE
Use each cell value as the anchor price. Typical dynamics:
- Budget buyer: anchor − 10–15% (floor = cost + freight)
- Mid-market: anchor ± 5–10%
- Premium/tender: anchor + 10–25% (regulated, quality premium)
- Injection/infusion: always 4–10× the tablet price
KEY TAKEAWAYS
- Dosage form is the #1 price driver, not destination
- Light cells = easy-entry markets for small suppliers
- Dark cells = premium markets requiring regulatory investment
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Which Indian ports ship ritonavir, which global ports receive it, and which corridors are high-value vs bulk
KEY TAKEAWAY
Ritonavir leaves India through 6+ ports. The top 5 (HYDERABAD AIR, NHAVA SHEVA SEA (JNPT), MUNDRA SEA) handle 100.0% of total USD. AIR moves 82% of shipments.
S FOR SUPPLIERS
Use the dumbbell to classify your port as high-value hub or bulk workhorse. Note the short-sea routes — Bangladesh, Sri Lanka, Myanmar and East Africa are the easiest logistics corridors for first-time exporters.
B FOR BUYERS
Use the destination port ranking to find which Indian ports serve your market. The lead-time estimates tell you what transit time to expect.
Fig 8.1 HYDERABAD AIR handles $5.7M — top 6 Indian origin ports by trade value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one Indian port. Bar length = USD value. The largest ports handle the majority of trade.
Fig 8.2 BRUSSELS is the #1 global destination port — top 19 by USD value.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bar = one destination port worldwide. Bar length = USD value received from India.
§8.1 Reference transit times for key India → global corridors
| Route | Mode | Transit time | Notes |
|---|---|---|---|
| NHAVA SHEVA SEA (JNPT) → US East Coast | Sea | 22–28 days | Via Suez; 2–3 transshipments typical |
| NHAVA SHEVA SEA (JNPT) → Lagos (Nigeria) | Sea | 18–24 days | Direct liner service available |
| MUMBAI AIR (SAHAR) → New York JFK | Air | 3–5 days | Direct cargo; cold-chain available |
| MUNDRA SEA → Rotterdam | Sea | 20–26 days | Via Suez; Hamburg also served |
| HYDERABAD AIR → London Heathrow | Air | 2–4 days | Pharma-grade cargo corridor |
| CHENNAI SEA → Chittagong (Bangladesh) | Sea | 7–12 days | Short-sea route; high frequency |
| RAXAUL → Birgunj (Nepal) | Road | 1–2 days | Land border crossing |
| NHAVA SHEVA SEA (JNPT) → Mombasa (Kenya) | Sea | 14–20 days | Direct or via Colombo hub |
Table 8.1 — Reference times based on standard shipping corridors. Air = 2–5 days; sea = 7–28 days; road = 1–2 days. Add 3–7 days for customs clearance at destination.
08
PART IV — MARKET BEHAVIOR
Shipping Ports & Trade Routes
Trade corridors — origin port to mode of transport to destination region
KEY TAKEAWAY
AIR dominates at 82% of shipments. The alluvial traces every dollar from Indian origin port through transport mode to destination region.
AIR
$5.7M
99.1% of USD · 82.1% of ships
SEA
$52K
0.9% of USD · 17.9% of ships
Fig 8.3 The dominant corridor is HYDERABAD AIR → Air → Europe ($5.4M).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Left = Indian origin ports. Middle = transport mode. Right = destination region. Ribbon thickness = USD value; color = mode. Follow the thickest ribbons to find the highest-value corridors.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market concentration, supply-chain risk, and the dependency patterns that signal where to act
KEY TAKEAWAY
Grenada is the most concentrated destination (HHI 10000, 1 suppliers). Azerbaijan is the most competitive (HHI 9424).
S FOR SUPPLIERS
The HHI barbell shows where competitors have locked up a market (concentrated = poaching opportunity) vs where you must compete on quality (fragmented). The slope chart reveals who is gaining ground.
B FOR BUYERS
The HHI barbell tells you whether your country has enough supplier options. If concentrated (red zone), you have fewer alternatives.
Fig 9.1 Grenada (HHI 10,000) is the most concentrated — Azerbaijan (HHI 9,424) is the most competitive.
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
What is HHI? The Herfindahl-Hirschman Index measures how concentrated a market is among its suppliers. It ranges from 0 to 10,000. Below 1,500 (green zone) = many suppliers compete openly — healthy, competitive market with low risk. 1,500–2,500 (yellow zone) = a few suppliers hold significant share — moderate concentration. Above 2,500 (red zone) = one or two suppliers dominate the market — high risk for buyers who may lose supply, and hard to break into for new suppliers. Conclusion: 18 of 18 destination markets are concentrated (red zone). 0 are competitive (green zone). Buyers in red-zone markets should urgently qualify a second Indian supplier to reduce dependency risk.
§9.1 Single-source dependencies
| Buyer | Country | Sole supplier | USD | Ships | Risk |
|---|---|---|---|---|---|
| EXPEDITORS INTERNATI… | Belgium | HETERO LABS LTD | $5.1M | 5 | CRITICAL |
| OOO JODAS EXPOIM | Russia | JODAS EXPOIM PVT… | $292K | 1 | HIGH |
| ATLANTA MEDICARE CO … | Thailand | MYLAN LABORATORI… | $123K | 1 | HIGH |
| SEVEN PHARMA CHILE SPA | Chile | ANNORA PHARMA PV… | $86K | 1 | MEDIUM |
| SIAMAGNIPHARMA | Latvia | HETERO LABS LTD | $40K | 1 | MEDIUM |
| SAUDI AMAROX FOR IND… | Saudi Arabia | HETERO LABS LTD | $22K | 1 | MEDIUM |
| OFFICE PHARMACEUTIQU… | Gabon | M D PHARMACY | $18K | 1 | MEDIUM |
| MINISTERE DE LA SA | Togo | HETERO LABS LTD | $4K | 1 | MEDIUM |
Conclusion: 16 buyers depend on exactly one Indian supplier, representing $5.7M in trade. 1 are rated CRITICAL — if their sole supplier fails, they have no backup. For suppliers: each row is a competitor’s locked-in customer you can target.
§9.2 Multi-source resilience
| Buyer | Country | Suppliers | USD | Dominant | Resilience |
|---|
Conclusion: 0 of these buyers have HIGH resilience (3+ active suppliers). These are the hardest accounts to win but safest partners for long-term contracts.
09
PART V — ACTION
Strategic Opportunities & Action Plan
Market entry playbook and risk landscape by destination country
KEY TAKEAWAY
15 target markets with specific entry approaches. Large suppliers: focus on regulated Tier 1 markets. Small/mid-size: start with Tier 2–3 (low barrier, growing demand).
§9.3 Sourcing recommendations · Table 9.1
| Country | Tier | Lead | Price | Risk | Entry approach |
|---|---|---|---|---|---|
| Belgium | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Russia | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Thailand | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Chile | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| South Africa | Tier 3 (emerging) | 3–5 days (air) | $0.01–$0.10/unit | LOW | First-mover advantage |
| Latvia | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Saudi Arabia | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Gabon | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Grenada | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Togo | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Sierra Leone | Tier 3 (emerging) | 14–28 days (sea) | $1–$10/unit | LOW | First-mover advantage |
| Saint Lucia | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Kenya | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
| Iraq | Tier 3 (emerging) | 3–5 days (air) | $1–$10/unit | LOW | First-mover advantage |
| Mauritania | Tier 3 (emerging) | 3–5 days (air) | $0.10–$1/unit | LOW | First-mover advantage |
For suppliers: Tier 1 markets (US, UK, France) require regulatory investment but offer premium pricing. Tier 3 markets (emerging) have low barriers — ideal for first-time exporters. For buyers: Use the price band and lead time to benchmark your current supplier’s terms.
Fig 9.2 0 markets in the Growth Opportunity zone (competitive + growing). 15 in Fragile Dependency (concentrated + shrinking).
Source: TransData Nexus Pharma Trade Intelligence · Licensed database & govt sources
How to read: Each bubble = one destination. X-axis = HHI (concentration). Y-axis = growth %. Bubble size = USD. Green zone (top-left) = Growth Opportunity — competitive markets that are growing, best for new entrants. Red zone (bottom-right) = Fragile Dependency — concentrated + shrinking, high supply-chain risk. Conclusion: Key markets are the top growth opportunities.
09
PART V — ACTION
Action Plan & Easy-Entry Markets
12 prioritised actions + 15 low-competition destination countries for small & mid-size suppliers
KEY TAKEAWAY
Quick Wins: execute this quarter. Big Bets: plan for next 6–12 months. Plus 15 countries with ≤5 Indian suppliers — the best entry points for SMEs.
S
FOR SUPPLIERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A1 | Pitch top single-source buyer in Belgium | This Q | HIGH |
| A2 | Offer alternative to top multi-source buyer | This Q | HIGH |
| A3 | Audit Grenada lock-ins (HHI 10000) | This Q | MED |
| A5 | Enter Belgium (2 suppliers) | This Q | HIGH |
| A6 | Enter Russia (1 suppliers) | This Q | MED |
| A8 | Build Russia distribution | 6–12m | HIGH |
| A9 | Bundle injection/infusion catalog for premium markets | 6–12m | MED |
B
FOR BUYERS
| ID | Action | Timing | Impact |
|---|---|---|---|
| A4 | Monitor rising exporters (climbers) | This Q | MED |
| A7 | Register for Belgium tenders | 6–12m | HIGH |
| A10 | Track quarterly HHI shifts across key destinations | This Q | LOW |
| A11 | Map competitor buyer portfolios quarterly | This Q | MED |
| A12 | Qualify second source for single-source buyers | This Q | MED |
§9.4 Easy-entry markets — 15 countries with ≤5 Indian suppliers
| # | Country | Region | Suppliers | Q4 USD | Growth | Barrier | Why this is easy |
|---|---|---|---|---|---|---|---|
| 1 | Belgium | Other | 2 | $5.1M | -100% | LOW | Only 2 Indian suppliers — near-monopoly, easy second-source entry |
| 2 | Russia | Other | 1 | $292K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 3 | Thailand | Asia | 1 | $123K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 4 | Chile | Other | 1 | $86K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 5 | South Africa | Africa | 1 | $46K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 6 | Latvia | Other | 1 | $40K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 7 | Saudi Arabia | Other | 1 | $22K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 8 | Gabon | Africa | 1 | $18K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 9 | Grenada | Other | 1 | $8K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 10 | Togo | Africa | 1 | $4K | -100% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 11 | Sierra Leone | Africa | 1 | $3K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 12 | Saint Lucia | Other | 1 | $2K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 13 | Kenya | Africa | 1 | $2K | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 14 | Iraq | Other | 1 | $739 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
| 15 | Mauritania | Africa | 1 | $713 | 0% | LOW | Only 1 Indian suppliers — near-monopoly, easy second-source entry |
This report covers 28 2025-Q4 Ritonavir shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/ritonavir
10
PART VI — EVIDENCE REGISTER
Comprehensive Shipment Records by Region
Authoritative source behind all analytics in this report — every shipment appears exactly once
KEY TAKEAWAY
This section contains every one of the 28 2025-Q4 ritonavir shipments, organised by Region → Exporter → Shipment rows. No row is duplicated.
S FOR SUPPLIERS
Jump to any destination country to see exactly who your competitors ship to, what they charge, through which port, and how often.
B FOR BUYERS
Jump to your country to see every Indian ritonavir shipment that arrived in 2025-Q4: supplier, price, dosage, port.
§10.1 Global totals
SHIPMENTS
28
across all regions
TOTAL USD
$5.75M
2025-Q4 FOB value
UNITS
16.6M
tablets, capsules, etc.
SUPPLIERS
8
Indian exporters
BUYERS
18
global importers
COUNTRIES
18
destinations
§10.2 Regional breakdown
§10.3 Key insights from the data
Africa is the largest region at $73K (1.3%), spanning 6 countries.
8 Indian suppliers shipped to 18 buyers across 18 countries — average shipment value $205K.
Top 0 markets: .
Every row below is real customs data — date, importer, dosage, brand, quantity, unit price, total USD, origin port, destination port, and transport mode.
§10.4 How to read a country page
1
6 KPI cards — shipments, USD, qty, exporters, importers, avg unit price.
2
4 mini-lists — top exporters, importers, dosages, monthly trend.
3
Shipment register — every row grouped by exporter. No row is duplicated or omitted.
10
PART VI — DRILL-DOWN · AFRICA
Region: Africa
6 countries · 8 shipments · $73K · 4 Indian suppliers · 7 buyers
SHIPMENTS
8
USD
$73K
COUNTRIES
6
SUPPLIERS
4
BUYERS
7
HHI
5,320
concentrated
Top 6 destination countries in Africa
1
South Africa (62.3%)
$46K
2
Gabon (24.9%)
$18K
3
Togo (6.1%)
$4K
4
Sierra Leone (3.4%)
$3K
5
Kenya (2.3%)
$2K
6
Mauritania (1.0%)
$712.78
Top 4 Indian suppliers into Africa
1
HETERO LABS LTD
$50K
2
M D PHARMACY
$18K
3
MCCOY PHARMA PVT LTD
$3K
4
MYLAN LABORATORIES LTD
$2K
Top 5 Africa importers
1
OFFICE PHARMACEUTIQUE NATIONAL (OPN · Gabon
$18K
2
MINISTERE DE LA SA · Togo
$4K
3
SURGILINKS LTD · Kenya
$2K
4
ALL NATIONS PHARMACEUTICALS · Sierra Leone
$1K
5
SECRETARIAT EXECUTIF NATIONAL DE LU · Mauritania
$712.78
Top 2 dosage forms
1
Tablet
$71K
2
Unknown
$3K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 4 | $68K | $17K |
| Nov | 4 | $5K | $1K |
| Dec | 0 | $0.0000 | — |
Shipment register · 8 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — HETERO LABS LTD · 3 shipments · $50K | |||||||||||
| 1 | Oct 2025 | UNLISTED BUYER | South Africa | Tablet | 279.6K | NOS | $0.050 | $14K | HYDERABAD AIR | JOHANNESBURG - JOHAN | AIR |
| 2 | Oct 2025 | UNLISTED BUYER | South Africa | Tablet | 563.0K | NOS | $0.056 | $32K | NHAVA SHEVA SEA (JNPT) | Durban | SEA |
| 3 | Oct 2025 | MINISTERE DE LA SA | Togo | Tablet | 22.7K | NOS | $0.197 | $4K | HYDERABAD AIR | LOME | AIR |
| SUPPLIER #2 — M D PHARMACY · 1 shipments · $18K | |||||||||||
| 4 | Oct 2025 | OFFICE PHARMACEUTIQUE NATIONAL (OPN | Gabon | Tablet | 2.4K | NOS | $7.55 | $18K | MUNDRA SEA | Libreville | SEA |
| SUPPLIER #3 — MCCOY PHARMA PVT LTD · 2 shipments · $3K | |||||||||||
| 5 | Nov 2025 | ALL NATIONS PHARMACEUTICALS | Sierra Leone | 560 | PCS | $2.24 | $1K | NHAVA SHEVA SEA (JNPT) | Freetown | SEA | |
| 6 | Nov 2025 | UNKNOWN BUYER | Sierra Leone | 560 | PCS | $2.24 | $1K | NHAVA SHEVA SEA (JNPT) | Freetown | SEA | |
| SUPPLIER #4 — MYLAN LABORATORIES LTD · 2 shipments · $2K | |||||||||||
| 7 | Nov 2025 | SECRETARIAT EXECUTIF NATIONAL DE LU | Mauritania | Tablet | 3.1K | NOS | $0.233 | $712.78 | MUMBAI AIR (SAHAR) | NOUAKCHOTT | AIR |
| 8 | Nov 2025 | SURGILINKS LTD | Kenya | Tablet | 6.0K | NOS | $0.282 | $2K | MUMBAI AIR (SAHAR) | NAIROBI | AIR |
10
PART VI — DRILL-DOWN · ASIA
Region: Asia
6 countries · 7 shipments · $146K · 4 Indian suppliers · 7 buyers
SHIPMENTS
7
USD
$146K
COUNTRIES
6
SUPPLIERS
4
BUYERS
7
HHI
7,345
concentrated
Top 6 destination countries in Asia
1
Thailand (84.3%)
$123K
2
Saudi Arabia (14.7%)
$22K
3
Iraq (0.5%)
$739.48
4
Iran (0.4%)
$644.06
5
Azerbaijan (0.1%)
$111.81
6
United Arab Emirates (0.0%)
$2.72
Top 4 Indian suppliers into Asia
1
MYLAN LABORATORIES LTD
$123K
2
HETERO LABS LTD
$22K
3
VATS INDUSTRIES PVT LTD
$739.48
4
SPR ONCOCARE PVT LTD
$2.72
Top 6 Asia importers
1
ATLANTA MEDICARE CO LTD · Thailand
$123K
2
SAUDI AMAROX FOR INDUSTRY COMPANY · Saudi Arabia
$22K
3
RESIDENT REPRESENTATIVE OF UNDP · Iran
$644.06
4
ZEYTUN PHARMACEUTICALS LLC · Azerbaijan
$108.49
5
MINISTRY OF HEALTH OF THE · Azerbaijan
$3.32
6
SHIP FLIX · United Arab Emirates
$2.72
Top 3 dosage forms
1
Powder
$123K
2
Tablet
$22K
3
Unknown
$739.48
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 3 | $146K | $49K |
| Nov | 1 | $739.48 | $739.48 |
| Dec | 3 | $114.53 | $38.18 |
Shipment register · 7 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — MYLAN LABORATORIES LTD · 2 shipments · $123K | |||||||||||
| 1 | Oct 2025 | ATLANTA MEDICARE CO LTD | Thailand | Powder | 997 | KGS | $123.78 | $123K | HYDERABAD AIR | BANGKOK | AIR |
| 2 | Dec 2025 | ZEYTUN PHARMACEUTICALS LLC | Azerbaijan | Tablet | 36.0K | NOS | $0.0030 | $108.49 | MUMBAI AIR (SAHAR) | BAKU | AIR |
| SUPPLIER #2 — HETERO LABS LTD · 3 shipments · $22K | |||||||||||
| 3 | Oct 2025 | RESIDENT REPRESENTATIVE OF UNDP | Iran | Tablet | 3.2K | NOS | $0.199 | $644.06 | HYDERABAD AIR | TEHRAN | AIR |
| 4 | Oct 2025 | SAUDI AMAROX FOR INDUSTRY COMPANY | Saudi Arabia | Tablet | 60.5K | NOS | $0.356 | $22K | HYDERABAD AIR | JEDDAH | AIR |
| 5 | Dec 2025 | MINISTRY OF HEALTH OF THE | Azerbaijan | Tablet | 1.5K | NOS | $0.0023 | $3.32 | MUMBAI AIR (SAHAR) | BAKU | SEA |
| SUPPLIER #3 — VATS INDUSTRIES PVT LTD · 1 shipments · $739.48 | |||||||||||
| 6 | Nov 2025 | UNKNOWN BUYER | Iraq | 20 | NOS | $36.97 | $739.48 | DELHI AIR | BAGDAD, METROPOLITAN | AIR | |
| SUPPLIER #4 — SPR ONCOCARE PVT LTD · 1 shipments · $2.72 | |||||||||||
| 7 | Dec 2025 | SHIP FLIX | United Arab Emirates | Tablet | 20 | NOS | $0.136 | $2.72 | BANGALORE AIR | BENGHAZI | AIR |
10
PART VI — DRILL-DOWN · EUROPE
Region: Europe
3 countries · 8 shipments · $5.44M · 3 Indian suppliers · 4 buyers
SHIPMENTS
8
USD
$5.44M
COUNTRIES
3
SUPPLIERS
3
BUYERS
4
HHI
8,972
concentrated
Top 3 destination countries in Europe
1
Belgium (93.9%)
$5.10M
2
Russia (5.4%)
$292K
3
Latvia (0.7%)
$40K
Top 3 Indian suppliers into Europe
1
HETERO LABS LTD
$5.14M
2
JODAS EXPOIM PVT LTD
$292K
3
MYLAN LABORATORIES LTD
$3K
Top 4 Europe importers
1
EXPEDITORS INTERNATIONAL NV · Belgium
$5.10M
2
OOO JODAS EXPOIM · Russia
$292K
3
SIAMAGNIPHARMA · Latvia
$40K
4
MSF SUPPLY ASBL · Belgium
$3K
Top 2 dosage forms
1
Tablet
$5.14M
2
Capsule
$292K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 7 | $5.43M | $776K |
| Nov | 1 | $3K | $3K |
| Dec | 0 | $0.0000 | — |
Shipment register · 8 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — HETERO LABS LTD · 6 shipments · $5.14M | |||||||||||
| 1 | Oct 2025 | SIAMAGNIPHARMA | Latvia | Tablet | 164.2K | NOS | $0.245 | $40K | HYDERABAD AIR | RIGA | AIR |
| 2 | Oct 2025 | EXPEDITORS INTERNATIONAL NV | Belgium | Tablet | 2.2M | NOS | $0.570 | $1.27M | HYDERABAD AIR | BRUSSELS | AIR |
| 3 | Oct 2025 | EXPEDITORS INTERNATIONAL NV | Belgium | Tablet | 1.1M | NOS | $0.570 | $630K | HYDERABAD AIR | BRUSSELS | AIR |
| 4 | Oct 2025 | EXPEDITORS INTERNATIONAL NV | Belgium | Tablet | 2.2M | NOS | $0.558 | $1.25M | HYDERABAD AIR | BRUSSELS | AIR |
| 5 | Oct 2025 | EXPEDITORS INTERNATIONAL NV | Belgium | Tablet | 2.3M | NOS | $0.558 | $1.28M | HYDERABAD AIR | BRUSSELS | AIR |
| 6 | Oct 2025 | EXPEDITORS INTERNATIONAL NV | Belgium | Tablet | 1.2M | NOS | $0.585 | $673K | HYDERABAD AIR | BRUSSELS | AIR |
| SUPPLIER #2 — JODAS EXPOIM PVT LTD · 1 shipments · $292K | |||||||||||
| 7 | Oct 2025 | OOO JODAS EXPOIM | Russia | Capsule | 3.3M | NOS | $0.090 | $292K | HYDERABAD AIR | SHEREMETYEVO | AIR |
| SUPPLIER #3 — MYLAN LABORATORIES LTD · 1 shipments · $3K | |||||||||||
| 8 | Nov 2025 | MSF SUPPLY ASBL | Belgium | Tablet | 14.4K | NOS | $0.238 | $3K | MUMBAI AIR (SAHAR) | BRUSSELS | AIR |
10
PART VI — DRILL-DOWN · AMERICAS
Region: Americas
3 countries · 5 shipments · $95K · 2 Indian suppliers · 3 buyers
SHIPMENTS
5
USD
$95K
COUNTRIES
3
SUPPLIERS
2
BUYERS
3
HHI
8,184
concentrated
Top 3 destination countries in Americas
1
Chile (89.9%)
$86K
2
Grenada (8.2%)
$8K
3
Saint Lucia (1.9%)
$2K
Top 2 Indian suppliers into Americas
1
ANNORA PHARMA PVT LTD
$86K
2
HETERO LABS LTD
$10K
Top 1 Americas importers
1
SEVEN PHARMA CHILE SPA · Chile
$86K
Top 2 dosage forms
1
Capsule
$86K
2
Tablet
$10K
Monthly trend
| Month | Ships | USD | Avg/ship |
|---|---|---|---|
| Oct | 1 | $86K | $86K |
| Nov | 4 | $10K | $2K |
| Dec | 0 | $0.0000 | — |
Shipment register · 5 rows · grouped by exporter
| # | Date | Importer | Country | Dosage | Qty | Unit | Unit $ | Total $ | Origin | Dest | Mode |
|---|---|---|---|---|---|---|---|---|---|---|---|
| SUPPLIER #1 — ANNORA PHARMA PVT LTD · 1 shipments · $86K | |||||||||||
| 1 | Oct 2025 | SEVEN PHARMA CHILE SPA | Chile | Capsule | 3.1M | NOS | $0.027 | $86K | HYDERABAD AIR | SANTIAGO DE CHILE - | AIR |
| SUPPLIER #2 — HETERO LABS LTD · 4 shipments · $10K | |||||||||||
| 2 | Nov 2025 | UNLISTED BUYER | Grenada | Tablet | 96 | NOS | $28.93 | $3K | MUMBAI AIR (SAHAR) | ST GEORGE | AIR |
| 3 | Nov 2025 | UNLISTED BUYER | Grenada | Tablet | 96 | NOS | $25.99 | $2K | MUMBAI AIR (SAHAR) | ST GEORGE | AIR |
| 4 | Nov 2025 | UNKNOWN BUYER | Grenada | Tablet | 96 | NOS | $25.99 | $2K | MUMBAI AIR (SAHAR) | ST GEORGE | AIR |
| 5 | Nov 2025 | UNLISTED BUYER | Saint Lucia | Tablet | 216 | NOS | $8.59 | $2K | MUMBAI AIR (SAHAR) | ST LUCIA | AIR |
10
PART VI — EVIDENCE REGISTER
Indian Supplier Directory
All 8 Indian ritonavir exporters — complete list ranked by USD
KEY TAKEAWAY
This directory lists every Indian company that shipped ritonavir in 2025-Q4.
S FOR SUPPLIERS
Find yourself and your competitors. Compare shipment count, USD, and destination regions.
B FOR BUYERS
Search for potential Indian suppliers. Filter by dosage form and destination region.
| # | Supplier | City | Ships | USD | Dosage forms | Primary regions |
|---|---|---|---|---|---|---|
| 1 | HETERO LABS LTD | HYDERABAD | 16 | $5.22M | Tablet | Asia, Europe |
| 2 | JODAS EXPOIM PVT LTD | HYDERBAD | 1 | $292K | Capsule | Europe |
| 3 | MYLAN LABORATORIES LTD | NASHIK | 5 | $129K | Powder, Tablet | Asia, Africa |
| 4 | ANNORA PHARMA PVT LTD | SANGAREDY DISTRICT | 1 | $86K | Capsule | Americas |
| 5 | M D PHARMACY | Bhopal | 1 | $18K | Tablet | Africa |
| 6 | MCCOY PHARMA PVT LTD | BOISAR | 2 | $3K | Africa | |
| 7 | VATS INDUSTRIES PVT LTD | DDA SHED | 1 | $739.48 | Asia | |
| 8 | SPR ONCOCARE PVT LTD | BANGALORE | 1 | $2.72 | Tablet | Asia |
10
PART VI — EVIDENCE REGISTER
Global Buyer Directory
All 16 global ritonavir importers — complete list ranked by USD
KEY TAKEAWAY
This directory lists every company that imported Indian ritonavir in 2025-Q4.
S FOR SUPPLIERS
Search for potential customers by country and dosage form.
B FOR BUYERS
Find your company and see which Indian supplier serves you.
| # | Buyer | Country | Ships | USD | Primary supplier | Dosage forms |
|---|---|---|---|---|---|---|
| 1 | EXPEDITORS INTERNATIONAL NV | Belgium | 5 | $5.10M | HETERO LABS LTD | Tablet |
| 2 | OOO JODAS EXPOIM | Russia | 1 | $292K | JODAS EXPOIM PVT LTD | Capsule |
| 3 | ATLANTA MEDICARE CO LTD | Thailand | 1 | $123K | MYLAN LABORATORIES LTD | Powder |
| 4 | SEVEN PHARMA CHILE SPA | Chile | 1 | $86K | ANNORA PHARMA PVT LTD | Capsule |
| 5 | SIAMAGNIPHARMA | Latvia | 1 | $40K | HETERO LABS LTD | Tablet |
| 6 | SAUDI AMAROX FOR INDUSTRY COMPANY | Saudi Arabia | 1 | $22K | HETERO LABS LTD | Tablet |
| 7 | OFFICE PHARMACEUTIQUE NATIONAL (OPN | Gabon | 1 | $18K | M D PHARMACY | Tablet |
| 8 | MINISTERE DE LA SA | Togo | 1 | $4K | HETERO LABS LTD | Tablet |
| 9 | MSF SUPPLY ASBL | Belgium | 1 | $3K | MYLAN LABORATORIES LTD | Tablet |
| 10 | SURGILINKS LTD | Kenya | 1 | $2K | MYLAN LABORATORIES LTD | Tablet |
| 11 | ALL NATIONS PHARMACEUTICALS | Sierra Leone | 1 | $1K | MCCOY PHARMA PVT LTD | |
| 12 | SECRETARIAT EXECUTIF NATIONAL DE LU | Mauritania | 1 | $712.78 | MYLAN LABORATORIES LTD | Tablet |
| 13 | RESIDENT REPRESENTATIVE OF UNDP | Iran | 1 | $644.06 | HETERO LABS LTD | Tablet |
| 14 | ZEYTUN PHARMACEUTICALS LLC | Azerbaijan | 1 | $108.49 | MYLAN LABORATORIES LTD | Tablet |
| 15 | MINISTRY OF HEALTH OF THE | Azerbaijan | 1 | $3.32 | HETERO LABS LTD | Tablet |
| 16 | SHIP FLIX | United Arab Emirates | 1 | $2.72 | SPR ONCOCARE PVT LTD | Tablet |
This report covers 28 2025-Q4 Ritonavir shipments.
TransData Nexus tracks 3.37M+ shipments across all pharmaceuticals since 2020.
→ transdatanexus.com/pharmaceutical/ritonavir
Talk to our trade analyst
Need a custom ritonavir report or a deeper dive into any market? Our team is ready.
WhatsApp: +91 95950 78788 · transdatanexus.com
PHARMA TRADE INTELLIGENCE
Thank you for reading
This report is part of the TransData Nexus Pharma Trade Intelligence series, covering 366 pharmaceutical products exported from India.
Every figure is grounded in real commercial trade records — official customs filings and licensed databases. No surveys, no estimates, no fake data.
Need a custom report?
We can generate intelligence for any pharmaceutical product, any time period, any combination of source and destination countries.
Want deeper analysis?
Our team provides competitive intelligence, market entry strategy, and supply chain due diligence for pharma importers and exporters.
Scan for product page
WhatsApp: +91 95950 78788
Email: info@transdatanexus.com
Web: https://transdatanexus.com/pharmaceutical/ritonavir
© 2026 TransData Nexus. All rights reserved. This report is provided for informational purposes only.
Data sourced from official customs filings and licensed commercial trade databases.
Reproduction without permission is prohibited.
Explore the full Ritonavir product page
Live data, supplier directory, price trends, and trade route analysis